Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04337684 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Long Term Follow-up on Menkes Disease Patients

StatusActive, Not Recruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Lead sponsor: Cyprium Therapeutics, Inc. to Sentynl Therapeutics, Inc.v7 Show 4 more changesShow less
    • Primary completion date changed from estimate of Dec 31, 2023 to Feb 26, 2026
    • Trial status: Enrolling by Invitation to Active, Not Recruiting
    • Study completion date: Dec 31, 2023 to Aug 31, 2026
    • Study site revised
  2. Primary and study completion dates: Dec 31, 2022 to Dec 31, 2023v6
  3. Primary and study completion dates: Jul 31, 2022 to Dec 31, 2022v5
  4. Primary and study completion dates: Mar 31, 2021 to Jul 31, 2022v4
  5. Primary and study completion dates: Oct 31, 2020 to Mar 31, 2021v3
  6. Primary and study completion dates: May 31, 2020 to Oct 31, 2020v2
  7. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This study will collect long term follow-up data regarding overall survival and neurological parameters from patients previously identified and/or enrolled in Protocols 09-CH-0059 and 90-CH0149 and Historical Control data on Menkes disease patients.
Trial Details
NCT Number NCT04337684
Lead Sponsor Sentynl Therapeutics, Inc.
Conditions
(from sponsor)		 Menkes Disease
Related terms Menkes Kinky Hair Syndrome
Enrollment 50 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov